{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:28:55Z","timestamp":1778891335669,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012462","name":"Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK045735"],"award-info":[{"award-number":["P30DK045735"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK118005"],"award-info":[{"award-number":["K01DK118005"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11307-020-01490-z","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T19:02:46Z","timestamp":1583348566000},"page":"1124-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Body Mass Index and Age Effects on Brain 11\u03b2-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-6575","authenticated-orcid":false,"given":"Jason","family":"Bini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansel T.","family":"Hillmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Dominique","family":"Gallezot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Pracitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Labaree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kapinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Ropchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania M.","family":"Jastreboff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"1490_CR1","unstructured":"Centers for Disease Control and Prevention. Overweight and Obesity. https:\/\/www.cdc.gov\/obesity\/index.html. Accessed 20 Dec 2019"},{"key":"1490_CR2","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1210\/en.2010-0554","volume":"151","author":"BL Mason","year":"2010","unstructured":"Mason BL, Pariante CM, Jamel S, Thomas SA (2010) Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions. Endocrinology 151:5294\u20135305","journal-title":"Endocrinology"},{"key":"1490_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J (2013) 11 -Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93:1139\u20131206","journal-title":"Physiol Rev"},{"key":"1490_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000314272","volume":"92","author":"P Chanson","year":"2010","unstructured":"Chanson P, Salenave S (2010) Metabolic syndrome in Cushing\u2019s syndrome. Neuroendocrinology 92:96\u2013101","journal-title":"Neuroendocrinology"},{"key":"1490_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol Psychiatry 32:756\u2013765","journal-title":"Biol Psychiatry"},{"key":"1490_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2005.12.002","volume":"248","author":"MC Holmes","year":"2006","unstructured":"Holmes MC, Seckl JR (2006) The role of 11\u03b2-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol 248:9\u201314","journal-title":"Mol Cell Endocrinol"},{"key":"1490_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","volume":"32","author":"CS Wyrwoll","year":"2011","unstructured":"Wyrwoll CS, Holmes MC, Seckl JR (2011) 11\u03b2-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol 32:265\u2013286","journal-title":"Front Neuroendocrinol"},{"key":"1490_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db14-0287","volume":"63","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan M, Arnold SE (2014) Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 63:2253\u20132261","journal-title":"Diabetes"},{"key":"1490_CR9","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1073\/pnas.0306996101","volume":"101","author":"TC Sandeep","year":"2004","unstructured":"Sandeep TC, Yau JLW, MacLullich AMJ et al (2004) 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A 101:6734\u20136739","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1490_CR10","doi-asserted-by":"publisher","first-page":"207.e1","DOI":"10.1016\/j.neurobiolaging.2010.09.010","volume":"33","author":"AMJ MacLullich","year":"2012","unstructured":"MacLullich AMJ, Ferguson KJ, Reid LM et al (2012) 11\u03b2-Hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline. Neurobiol Aging 33:207.e1\u2013207.e8","journal-title":"Neurobiol Aging"},{"key":"1490_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/obr.12629","volume":"19","author":"S Alford","year":"2018","unstructured":"Alford S, Patel D, Perakakis N, Mantzoros CS (2018) Obesity as a risk factor for Alzheimer\u2019s disease: weighing the evidence. Obes Rev 19:269\u2013280","journal-title":"Obes Rev"},{"key":"1490_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0531-5565(94)00065-B","volume":"30","author":"MJ Meaney","year":"1995","unstructured":"Meaney MJ, O\u2019Donnell D, Rowe W et al (1995) Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol 30:229\u2013251","journal-title":"Exp Gerontol"},{"key":"1490_CR13","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1176\/ajp.2006.163.12.2164","volume":"163","author":"JG Csernansky","year":"2006","unstructured":"Csernansky JG, Dong H, Fagan AM et al (2006) Plasma cortisol and progression of dementia in subjects with alzheimer-type dementia. Am J Psychiatry 163:2164\u20132169","journal-title":"Am J Psychiatry"},{"key":"1490_CR14","unstructured":"Yau JLW, Seckl JR (2012) Local amplification of glucocorticoids in the aging brain and impaired spatial memory. 4:1\u201315"},{"key":"1490_CR15","first-page":"1022","volume":"84","author":"PM Stewart","year":"1999","unstructured":"Stewart PM, Boulton A, Kumar S et al (1999) Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022\u20131027","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR16","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","volume":"86","author":"E Rask","year":"2001","unstructured":"Rask E (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418\u20131421","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR17","doi-asserted-by":"publisher","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","volume":"111","author":"SA Morgan","year":"2014","unstructured":"Morgan SA, McCabe EL, Gathercole LL et al (2014) 11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 111:E2482\u2013E2491","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1490_CR18","doi-asserted-by":"crossref","unstructured":"Holmes MC, Carter RN, Noble J, et al (2010) 11\u03b2-Hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse Hippocampus and parietal cortex and causes memory impairments. 30:6916\u20136920","DOI":"10.1523\/JNEUROSCI.0731-10.2010"},{"key":"1490_CR19","first-page":"277","volume":"87","author":"R Andrew","year":"2002","unstructured":"Andrew R, Smith K, Jones GC, Walker BR (2002) Distinguishing the activities of 11\u03b2-Hydroxysteroid. J Clin Endocrinol Metab 87:277\u2013285","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR20","first-page":"1050","volume":"57","author":"A Iwashita","year":"2016","unstructured":"Iwashita A, Fushiki H, Fujita Y et al (2016) Discovery of a novel radioligand [11C] AS2471907 for PET imaging of the brain 11\u03b2-HSD1. J Nucl Med 57:1050","journal-title":"J Nucl Med"},{"key":"1490_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2967\/jnumed.118.219766","volume":"60","author":"J-D Gallezot","year":"2019","unstructured":"Gallezot J-D, Nabulsi N, Henry S et al (2019) Imaging the enzyme 11\u03b2-hydroxysteroid dehydrogenase type 1 with positron emission tomography: evaluation of the novel radiotracer 11C-AS2471907 in human brain. J Nucl Med 60:1140\u20131146","journal-title":"J Nucl Med"},{"key":"1490_CR22","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1021\/acschemneuro.8b00715","volume":"10","author":"E Baum","year":"2019","unstructured":"Baum E, Zhang W, Li S, Cai Z, Holden D, Huang Y (2019) A novel 18F-labeled radioligand for positron emission tomography imaging of 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2-HSD1): synthesis and preliminary evaluation in nonhuman primates. ACS Chem Neurosci 10:2450\u20132458","journal-title":"ACS Chem Neurosci"},{"key":"1490_CR23","unstructured":"Bhatt S, Nabulsi NB, Li S, et al (2019) First in-human PET study and kinetic evaluation of [18 F]AS2471907 for imaging 11\u03b2-hydroxysteroid dehydrogenase type 1. J Cereb Blood Flow Metab 271678X19838633"},{"key":"1490_CR24","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2967\/jnumed.115.166850","volume":"57","author":"M Naganawa","year":"2016","unstructured":"Naganawa M, Waterhouse RN, Nabulsi N, Lin SF, Labaree D, Ropchan J, Tarabar S, DeMartinis N, Ogden A, Banerjee A, Huang Y, Carson RE (2016) First-in-human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430. J Nucl Med 57:1388\u20131395","journal-title":"J Nucl Med"},{"key":"1490_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273\u2013289","journal-title":"Neuroimage"},{"key":"1490_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"key":"1490_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","volume":"22","author":"M Ichise","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE (2002) Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 22:1271\u20131281","journal-title":"J Cereb Blood Flow Metab"},{"key":"1490_CR28","first-page":"3330","volume":"87","author":"E Rask","year":"2002","unstructured":"Rask E, Walker BR, S\u00f6derberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330\u20133336","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR29","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1210\/jc.2003-032240","volume":"89","author":"G Valsamakis","year":"2004","unstructured":"Valsamakis G, Anwar A, Tomlinson JW et al (2004) 11Beta-Hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:4755\u20134761","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR30","doi-asserted-by":"publisher","first-page":"e29531","DOI":"10.1371\/journal.pone.0029531","volume":"7","author":"A Ahmed","year":"2012","unstructured":"Ahmed A, Rabbitt E, Brady T et al (2012) A switch in hepatic cortisol metabolism across the Spectrum of non alcoholic fatty liver disease. PLoS One 7:e29531","journal-title":"PLoS One"},{"key":"1490_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jne.12447","volume":"29","author":"S Caughey","year":"2017","unstructured":"Caughey S, Harris AP, Seckl JR et al (2017) Forebrain-specific transgene rescue of 11\u03b2-HSD1 associates with impaired spatial memory and reduced hippocampal brain-derived neurotrophic factor mRNA levels in aged 11B-HSD1 deficient mice. J Neuroendocrinol 29:1\u20139","journal-title":"J Neuroendocrinol"},{"key":"1490_CR32","doi-asserted-by":"publisher","first-page":"13867","DOI":"10.1523\/JNEUROSCI.2783-10.2010","volume":"30","author":"K Sooy","year":"2010","unstructured":"Sooy K, Webster SP, Noble J et al (2010) Partial deficiency or short-term inhibition of 11B-dydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice. J Neurosci 30:13867\u201313872","journal-title":"J Neurosci"},{"key":"1490_CR33","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.1523\/JNEUROSCI.2190-07.2007","volume":"27","author":"JLW Yau","year":"2007","unstructured":"Yau JLW, Mcnair KM, Noble J et al (2007) Enhanced hippocampal long-term potentiation and spatial learning in aged 11\u03b2-hydroxysteroid dehydrogenase type 1 knock-out mice. J Neurosci 27:10487\u201310496","journal-title":"J Neurosci"},{"key":"1490_CR34","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1210\/en.2015-1395","volume":"156","author":"K Sooy","year":"2015","unstructured":"Sooy K, Noble J, Mcbride A et al (2015) Cognitive and disease-modifying effects of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition in male Tg2576 mice, a model of Alzheimer\u2019s disease. Endocrinology 156:4592\u20134603","journal-title":"Endocrinology"},{"key":"1490_CR35","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1073\/pnas.071562698","volume":"98","author":"JL Yau","year":"2001","unstructured":"Yau JL, Noble J, Kenyon CJ et al (2001) Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci U S A 98:4716\u20134721","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1490_CR36","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1523\/JNEUROSCI.14-05-02893.1994","volume":"14","author":"S Lupien","year":"1994","unstructured":"Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meaney MJ (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893\u20132903","journal-title":"J Neurosci"},{"key":"1490_CR37","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jocn.2008.12.026","volume":"16","author":"CW Huang","year":"2009","unstructured":"Huang CW, Lui CC, Chang WN, Lu CH, Wang YL, Chang CC (2009) Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer\u2019s disease. J Clin Neurosci 16:1283\u20131286","journal-title":"J Clin Neurosci"},{"key":"1490_CR38","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1038\/sj.ejcn.1601025","volume":"54","author":"B Beaufr\u00e8re","year":"2000","unstructured":"Beaufr\u00e8re B, Morio B (2000) Fat and protein redistribution with aging: metabolic considerations. Eur J Clin Nutr 54:S48\u2013S53","journal-title":"Eur J Clin Nutr"},{"key":"1490_CR39","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/en.2008-0088","volume":"149","author":"A Balachandran","year":"2008","unstructured":"Balachandran A, Guan H, Sellan M, van Uum S, Yang K (2008) Insulin and dexamethasone dynamically regulate adipocyte 11\u03b2-hydroxysteroid dehydrogenase type 1. Endocrinology 149:4069\u20134079","journal-title":"Endocrinology"},{"key":"1490_CR40","first-page":"2468","volume":"81","author":"E Van Cauter","year":"2014","unstructured":"Van Cauter E, Leproult R, Kupfer D (2014) Effects of gender and age on the levels rhythmicity. J Clin Endocrinol Metab 81:2468\u20132473","journal-title":"J Clin Endocrinol Metab"},{"key":"1490_CR41","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1212\/WNL.0000000000006879","volume":"92","author":"M Hamer","year":"2019","unstructured":"Hamer M, Batty GD (2019) Association of body mass index and waist-to-hip ratio with brain structure: UK biobank study. Neurology 92:e594\u2013e600","journal-title":"Neurology"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01490-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-020-01490-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01490-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:27:33Z","timestamp":1695871653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-020-01490-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s11307-020-01490-z","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"4 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"AMJ consults for Novo Nordisk, Medtronic Diabetes, and Rhythm Pharmaceuticals. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}